Detection of HA-hM3Dq using western blot
To assess HA-tagged hM3Dq DREADD expression in the hippocampus and cortex of CamKIIα-tTA::TetO-hM3Dq bigenic mice on postnatal day 7 (P7), we performed western blotting analysis for the HA antigen.
Tissue samples were dissected and stored at -80 °C, and then homogenized in Radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris-Cl (pH 8.0), 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl) using a Dounce homogenizer. The lysis buffer contained protease and phosphatase inhibitors (Sigma Aldrich, United States).
Following the estimation of protein concentration using the Quantipro BCA assay kit (Sigma-Alrich, United States), equal amounts of lysate (40 ug) were resolved on a 10% sodium dodecyl sulfate polyacrylamide gel and then transferred onto polyvinylidene fluoride membranes (100V, 80-90 minutes, wet transfer).
Blots were blocked in 5% milk dissolved in TBST for one hour, and subsequently incubated overnight with rabbit anti-HA antibody (1:1500 in 5% milk, Cat. No. H6908, Sigma-Aldrich, United States). Following subsequent washes with TBST, blots were exposed to HRP conjugated goat anti-rabbit secondary antibody (1:6000, Cat. No. AS014, Abclonal Technology, United States) for one hour. Signal was visualized using a GE Amersham Imager 600 (GE life sciences) with a western blotting detection kit (WesternBright ECL, Advansta, United States). Densitometric quantitative analysis was performed using ImageJ software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.